NDC 55111-609

NDC 55111-609

NDC 55111-609 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 55111-609
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 55111-609-90 [55111060990]

Duloxetine CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryANDA
Application NumberANDA090723
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-06-18
Marketing End Date2016-06-17

NDC 55111-609-10 [55111060910]

Duloxetine CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryANDA
Application NumberANDA090723
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-06-18
Marketing End Date2016-06-17

NDC 55111-609-79 [55111060979]

Duloxetine CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryANDA
Application NumberANDA090723
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-06-18
Marketing End Date2016-06-17

NDC 55111-609-30 [55111060930]

Duloxetine CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryANDA
Application NumberANDA090723
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-06-18
Marketing End Date2016-06-17

NDC 55111-609-81 [55111060981]

Duloxetine CAPSULE, DELAYED RELEASE PELLETS
Marketing CategoryANDA
Application NumberANDA090723
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-06-18
Marketing End Date2016-06-17

Drug Details

Medicade Reported Pricing

55111060930 DULOXETINE HCL DR 30 MG CAP

Pricing Unit: EA | Drug Type:
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.